Paclitaxel Treatment Options

A collection of 2048 research studies where Paclitaxel is the interventional treatment. These studies are located in the United States . Paclitaxel is used for conditions such as Breast Cancer, Ovarian Cancer and Non-Small Cell Lung Cancer.

Home

All Treatments

Paclitaxel

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Offer

Lose Weight with GLP-1 Medications

Recruiting

Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.

As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples

NCT04683315

Recruiting

This is an open-label, phase II study in patients with resectable and borderline resectable pancreatic cancer.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/19/2024

Locations: HonorHealth Medical Group, Scottsdale, Arizona +1 locations

Conditions: Pancreatic Cancer

Learn More ›

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

NCT00889382

Completed

This is a multi-center, randomized, open-label, phase 1/2 study of continuous weekly paclitaxel and escalating doses of intermittent or continuous OSI-906 in patients with recurrent/relapsed ovarian and other solid tumors.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/18/2024

Locations: Mayo Clinic, Scottsdale, Arizona +45 locations

Mayo Clinic, Scottsdale, Arizona

Department of Obstetrics and Gynecology, University of California, Irvine, Orange, California

Horizon Oncology Center, Lafayette, Indiana

Ochsner Clinic Foundation, New Orleans, Louisiana

Morristown Memorial Hospital, Morristown, New Jersey

Blumenthal Cancer Center - Main, Charlotte, North Carolina

Duke University Medical Center, Durham, North Carolina

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

WestMead Hospital, WestMead, New South Wales

Mater Adult Hospital, South Brisbane, Queensland

Royal Adelaide Hospital, North Terrace, South Australia

Launceston General Hospital, Launceston, Tasmania

Frankston Hospital, Frankston, Victoria

Border Medical Oncology, Wodonga, Victoria

St. John of God Hospital, Bunbury, Bunbury, Western Australia

Sir Charles Gairdner Hospital, Perth, Western Australia

St. John of Gog Hospital, Subiaco, Subiaco, Western Australia

Juravinski Cancer Center, Hamilton, Ontario

Princess Margaret Hospital, Toronto, Ontario

McGill University, Montreal, Quebec

University Hospital Hradec Kralove, Kralove, Not set

University Hospital Ostrava, Ostrava- Poruba, Not set

General University Hospital, Department of Obstetrics and Gynecology, Prague, Not set

Universitaria di Bologna Policlinico, Bologna, Not set

Ospedale di Carpi, AUSL di Modena, Carpi, Not set

Instituto Europeo di Oncologia, Milan, Not set

Oncology IDI- IRCSS, Roma, Not set

III Oddzial Onkologii Ginekologicznej, Lublin, Not set

Oddzial Radioterapii, Poznan, Not set

Klinika Onkologii AM w Poznaniu, Poznan, Not set

Institutul Oncologic Prof. Dr. Ion. Chiricuta Sectia de Oncologie Medicala, Cluj Napoca, Not set

Institutul Oncologic Prof. Dr. Ion. Chiricuta Sectia Radiologie, Cluj Napoca, Not set

Oncology Medical Centre SCM, Iasi, Not set

Clinical Caunty Hospital Mures, Mures, Not set

Central Clinical Hospital, Moscow, Not set

Moscow City Oncology Hospital, Moscow, Not set

State Institution Medical Radiology Scientific Center, Obninsk, Not set

Sity Clinical Oncology, St. Petersburg, Not set

Ospedale San Giovanni, Bellinzona, Not set

Drug Development Unit Royal Mardsen NHS Foundation Trust, Sutton, Surrey

Royal Marsden Hospital, London, Not set

University College Hospital, London, Not set

The Christie NHS Foundation Trust, Manchester, Not set

Mount Vernon Cancer Center, Northwood, Not set

Churchill Hospital, Oxford, Not set

Christie NHS Foundation Trust, Withington, Not set

Conditions: Ovarian Cancer, Solid Tumors

Learn More ›

HOT: HIPEC in Ovarian Cancer as Initial Treatment

NCT02124421

Active Not Recruiting

Community hospital based phase II (prospective randomized) study to evaluate the toxicity of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in newly diagnosed, otherwise untreated, advanced stage (stage III/IV) epithelial ovarian, fallopian tube, and primary peritoneal cancer.

Gender:

FEMALE

Ages:

Between 18 years and 80 years

Trial Updated:

11/18/2024

Locations: Mercy Medical Center, Baltimore, Maryland

Conditions: Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Ovarian Carcinoma, Fallopian Tube Carcinoma

Learn More ›

An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)

NCT02477826

Completed

The purpose of this study is to show that Nivolumab, or Nivolumab plus Ipilimumab, or Nivolumab plus Platinum-Doublet Chemotherapy improves progression free survival and/or overall survival compared with chemotherapy in patients with advanced lung cancer.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/16/2024

Locations: Southern Cancer Center, Inc., Mobile, Alabama +289 locations

Southern Cancer Center, Inc., Mobile, Alabama

Local Institution - 0017, San Francisco, California

Local Institution - 0021, New Haven, Connecticut

Local Institution - 0001, Atlanta, Georgia

Local Institution - 0013, Marietta, Georgia

Local Institution - 0004, Lexington, Kentucky

Local Institution - 0115, Saint Louis, Missouri

Local Institution - 0005, Buffalo, New York

Local Institution - 0019, New York, New York

Local Institution - 0014, Cleveland, Ohio

Local Institution - 0009, Columbus, Ohio

Local Institution - 0007, Allentown, Pennsylvania

Local Institution - 0075, Langhorne, Pennsylvania

Local Institution - 0299, Philadelphia, Pennsylvania

Local Institution - 0012, Philadelphia, Pennsylvania

Local Institution - 0015, Sayre, Pennsylvania

Local Institution - 0008, Charleston, South Carolina

Local Institution - 0080, Greenville, South Carolina

Local Institution - 0010, Greenville, South Carolina

Local Institution - 0020, Nashville, Tennessee

Local Institution - 0306, Dallas, Texas

Local Institution - 0003, Dallas, Texas

Local Institution - 0102, Houston, Texas

Local Institution - 0011, Salt Lake City, Utah

Local Institution - 0074, Kennewick, Washington

Local Institution - 0170, Berazategui, Buenos Aires

Local Institution - 0171, Capital Federal, Buenos Aires

Local Institution - 0172, Ciudad Autonoma De Buenos Aire, Buenos Aires

Local Institution - 0176, Ciudad de Buenos Aires, Buenos Aires

Local Institution - 0296, Mar Del Plata, Buenos Aires

Local Institution - 0177, Viedma, RIO Negro

Local Institution - 0130, San Miguel de Tucuman, Tucuman

Local Institution - 0268, Cordoba, Not set

Local Institution - 0272, Córdoba, Not set

Local Institution - 0297, Córdoba, Not set

Local Institution - 0182, Garran, Australian Capital Territory

Local Institution - 0301, Blacktown, New South Wales

Local Institution - 0300, Gosford, New South Wales

Local Institution - 0045, Brisbane, Queensland

Local Institution - 0046, Elizabeth Vale, South Australia

Local Institution - 0043, Clayton, Victoria

Local Institution - 0042, Fitzroy, Victoria

Local Institution - 0180, Perth, Western Australia

Local Institution - 0040, Murdoch, Not set

Local Institution - 0183, North Tamworth, Not set

Local Institution - 0241, Graz, Not set

Local Institution - 0240, Vienna, Not set

Local Institution - 0239, Wels, Not set

Local Institution - 0121, Roeselare, West-Vlaanderen

Local Institution - 0030, Edegem, Not set

Local Institution - 0031, Gent, Not set

Local Institution - 0034, Gilly, Not set

Local Institution - 0117, Hasselt, Not set

Local Institution - 0033, Sint Niklaas, Not set

Local Institution - 0125, Salvador, Bahia

Local Institution - 0124, Ijui, RIO Grande DO SUL

Local Institution - 0123, Porto Alegre, Rio Grande Do Sul

Local Institution - 0127, Barretos, Sao Paulo

Local Institution - 0129, Rio De Janeiro, Not set

Local Institution - 0144, Sao Paulo, Not set

Local Institution - 0126, Sao Paulo, Not set

Local Institution - 0128, Sao Paulo, Not set

Local Institution - 0103, Edmonton, Alberta

Local Institution - 0290, St. John's, Newfoundland and Labrador

Local Institution - 0104, London, Ontario

Local Institution - 0122, Montreal, Quebec

Local Institution - 0106, Quebec City, Quebec

Local Institution - 0107, Rimouski, Quebec

Local Institution - 0291, Sherbrooke, Quebec

Local Institution - 0292, Trois-Rivieres, Quebec

Local Institution - 0302, Quebec, Not set

Local Institution - 0173, Santiago, Metropolitana

Local Institution - 0131, Santiago, Región Metropolitana De Santiago

Local Institution - 0174, Vina Del Mar, Valparaiso

Local Institution - 0380, Hefei, Anhui

Local Institution - 0313, Beijing, Beijing

Local Institution - 0315, Beijing, Beijing

Local Institution - 0316, Beijing, Beijing

Local Institution - 0314, Beijing, Beijing

Local Institution - 0365, Chongqing, Chongqing

Local Institution - 0364, Chongqing, Chongqing

Local Institution - 0378, Chongqing, Chongqing

Local Institution - 0322, Guangzhou, Guangdong

Local Institution - 0372, Guangzhou, Guangdong

Local Institution - 0319, Guanzhou, Guangdong

Local Institution - 0323, Haikou, Hainan

Local Institution - 0325, Haerbin, Heilongjiang

Local Institution - 0324, Zhengzhou, Henan

Local Institution - 0379, Zhengzhou, Henan

Local Institution - 0375, Wuhan, Hubei

Local Institution - 0362, Changsha, Hunan

Local Institution - 0347, Nanchang, Jiangxi

Local Institution - 0329, Changchun, Jilin

Local Institution - 0361, Changchun, Jilin

Local Institution - 0359, Shenyang, Liaoning

Local Institution - 0371, Xi'an, Shaanxi

Local Institution - 0333, Xi'an, Shan3xi

Local Institution - 0360, Qingdao, Shandong

Local Institution - 0334, Shanghai, Shanghai

Local Institution - 0376, Chengdu, Sichuan

Local Institution - 0373, Tianjin, Tianjin

Local Institution - 0340, Urumqi, Xinjiang

Local Institution - 0343, Hangzhou, Zhejiang

Local Institution - 0370, Hangzhou, Zhejiang

Local Institution - 0342, Hangzhou, Zhejiang

Local Institution - 0328, Changsha, Not set

Local Institution - 0341, Hangzhou, Not set

Local Institution - 0345, Kunming, Not set

Local Institution - 0336, Shanghai, Not set

Local Institution - 0337, Shanghai, Not set

Local Institution - 0374, Shantou, Not set

Local Institution - 0273, Pereira, Risaralda

Local Institution - 0237, Bogota, Not set

Local Institution - 0238, Bogota, Not set

Local Institution - 0282, Medellin, Not set

Local Institution - 0112, Hradec Kralove, Not set

Local Institution - 0113, Olomouc, Not set

Local Institution - 0111, Praha 4, Not set

Local Institution - 0232, Pribram, Not set

Local Institution - 0270, Oulu, Not set

Local Institution - 0271, Turku, Not set

Local Institution - 0222, Bron, Rhône

Local Institution - 0216, ANGERS Cedex 2, Not set

Local Institution - 0229, Besançon Cedex, Not set

Local Institution - 0283, Caen, Not set

Local Institution - 0218, Creteil, Not set

Local Institution - 0228, Limoges, Not set

Local Institution - 0215, Marseille Cedex 20, Not set

Local Institution - 0230, Paris, Not set

Local Institution - 0227, Pessac, Not set

Local Institution - 0223, Rennes, Not set

Local Institution - 0225, Rouen, Not set

Local Institution - 0221, Saint Priest En Jarez, Not set

Local Institution - 0217, Saint-herblain Cedex, Not set

Local Institution - 0224, Strasbourg, Not set

Local Institution - 0226, Toulon, Not set

Local Institution - 0231, Magdeburg, Sachsen-Anhalt

Local Institution - 0213, Bad Berka, Not set

Local Institution - 0208, Berlin, Not set

Local Institution - 0205, Essen, Not set

Local Institution - 0210, Frankfurt, Not set

Local Institution - 0211, Gera, Not set

Local Institution - 0203, Grosshansdorf, Not set

Local Institution - 0209, Halle, Not set

Local Institution - 0202, Heidelberg, Not set

Local Institution - 0214, Hemer, Not set

Local Institution - 0206, Immenstadt, Not set

Local Institution - 0204, Muenchen, Not set

Local Institution - 0201, Stuttgart, Not set

Local Institution - 0212, Wiesbaden, Not set

Local Institution - 0094, Athens, Attikí

Local Institution - 0095, Heraklion, Not set

Local Institution - 0190, Neo Faliro, Not set

Local Institution - 0101, Thessaloniki, Not set

Local Institution - 0025, Budapest, Not set

Local Institution - 0024, Budapest, Not set

Local Institution - 0026, Matrahaza, Not set

Local Institution - 0054, Dublin 8, Dublin

Local Institution - 0053, Beaumont, Not set

Local Institution - 0055, Galway, Not set

Local Institution - 0100, Limerick, Not set

Local Institution - 0187, Jerusalem, Not set

Local Institution - 0186, Kfar-saba, Not set

Local Institution - 0185, Petach Tikva, Not set

Local Institution - 0184, Tel-hashomer, Not set

Local Institution - 0188, Zerifin, Not set

Local Institution - 0083, Milan, Lombardia

Azienda Ospedaliera Moscati, Avellino, Not set

Local Institution - 0179, Bergamo, Not set

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Not set

Local Institution - 0084, Livorno, Not set

Policlinico G. Martino, Messina, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Not set

Istituto Nazionale Tumori Fondazione Pascale, Napoli, Not set

Local Institution - 0087, Perugia, Not set

Ospedale Santa Maria delle Croci, Ravenna, Not set

Ifo-Istituto Regina Elena, Roma, Not set

Local Institution - 0089, Roma, Not set

Local Institution - 0085, Terni, Not set

Local Institution - 0153, Nagoya-shi, Aichi

Local Institution - 0152, Nagoya, Aichi

Local Institution - 0148, Kashiwa-shi, Chiba

Local Institution - 0159, Matsuyama, Ehime

Local Institution - 0160, Fukuoka-shi, Fukuoka

Local Institution - 0259, Kurume-shi, Fukuoka

Local Institution - 0255, Ota-shi, Gunma

Local Institution - 0258, Hiroshima-shi, Hiroshima

Local Institution - 0163, Sapporo-shi, Hokkaido

Local Institution - 0253, Sapporo-shi, Hokkaido

Local Institution - 0252, Akashi-shi, Hyogo

Local Institution - 0156, Kobe-shi, Hyogo

Local Institution - 0146, Kanazawa-shi, Ishikawa

Local Institution - 0161, Yokohama-shi, Kanagawa

Local Institution - 0150, Yokohama-Shi, Kanagawa

Local Institution - 0275, Natori-shi, Miyagi

Local Institution - 0254, Sendai-shi, Miyagi

Local Institution - 0145, Sendai-shi, Miyagi

Local Institution - 0164, Niigata-shi, Niigata

Local Institution - 0158, Kurashiki-shi, Okayama

Local Institution - 0155, Hirakata-shi, Osaka

Local Institution - 0154, Osaka-shi, Osaka

Local Institution - 0251, Osakasayama-shi, Osaka

Local Institution - 0257, Takatsuki-shi, Osaka

Local Institution - 0353, Hidaka-shi, Saitama

Local Institution - 0256, Kitaadachi-gun, Saitama

Local Institution - 0151, Sunto-gun, Shizuoka

Local Institution - 0147, Chuo-ku, Tokyo

Local Institution - 0149, Koto-ku, Tokyo

Local Institution - 0278, Shinjuku-ku, Tokyo

Local Institution - 0157, Wakayama-shi, Wakayama

Local Institution - 0354, Ube-shi, Yamaguchi

Local Institution - 0260, Chiba, Not set

Local Institution - 0165, Okayama, Not set

Local Institution - 0162, Tokyo, Not set

Local Institution - 0136, Seongnam-si, Kyǒnggi-do

Local Institution - 0249, Cheongju-si, Not set

Local Institution - 0133, Gangnam-gu, Not set

Local Institution - 0132, Seoul, Not set

Local Institution - 0135, Seoul, Not set

Local Institution - 0287, Beirut, Not set

Local Institution - 0286, Beirut, Not set

Local Institution - 0196, Df, Distrito Federal

Local Institution - 0193, Mexico, Distrito Federal

Local Institution - 0198, Cuautitlan, Estado DE Mexico

Local Institution - 0197, Guadalajara, Jalisco

Local Institution - 0191, Zapopan, Jalisco

Local Institution - 0267, Morelia, Michoacan

Local Institution - 0277, Monterrey, Nuevo Leon

Local Institution - 0303, Merida, Yucatán

Local Institution - 0192, Chihuahua, Not set

Local Institution - 0195, San Luis Potosi, Not set

Local Institution - 0236, San Luis Potosi, Not set

Local Institution - 0194, Toluca, Not set

Local Institution - 0036, Amsterdam, Not set

Local Institution - 0189, Amsterdam, Not set

Local Institution - 0169, Breda, Not set

Local Institution - 0037, Rotterdam, Not set

Local Institution - 0039, Veldhoven, Not set

Local Institution - 0262, Lima, Not set

Local Institution - 0263, Lima, Not set

Local Institution - 0350, Lima, Not set

Local Institution - 0261, Lima, Not set

Local Institution - 0351, Lima, Not set

Local Institution - 0060, Bydgoszcz, Not set

Local Institution - 0058, Gdansk, Not set

Local Institution - 0063, Gdynia, Not set

Local Institution - 0072, Gliwice, Not set

Local Institution - 0057, Lodz, Not set

Local Institution - 0059, Warszawa, Not set

Local Institution - 0070, Wroclaw, Not set

Local Institution - 0167, Craiova, Not set

Local Institution - 0250, Floresti, Not set

Local Institution - 0166, Romania, Not set

Local Institution - 0284, Sector 2, Not set

Local Institution - 0137, Chelyabinsk, Not set

Local Institution - 0142, Kazan, Not set

Local Institution - 0022, Moscow, Not set

Local Institution - 0049, Saint-Petersburg, Not set

Local Institution - 0028, St. Petersburg, Not set

Local Institution - 0027, St. Petersburg, Not set

Local Institution - 0143, Ufa, Not set

Local Institution - 0264, Pretoria, Gauteng

Local Institution - 0234, Sandton, Gauteng

Local Institution - 0233, Saxonwold, Johannesburg, Gauteng

Local Institution - 0305, Vereeniging, Not set

Local Institution - 0064, Majadahonda, Madrid

Local Institution - 0066, Barcelona, Not set

Local Institution - 0067, Barcelona, Not set

Local Institution - 0065, Madrid, Not set

Local Institution - 0069, Sevilla, Not set

Local Institution - 0068, Valencia, Not set

Local Institution - 0243, Basel, Not set

Local Institution - 0246, Chur, Not set

Local Institution - 0244, Lausanne, Not set

Local Institution - 0245, Winterthur, Not set

Local Institution - 0139, Taichung, Not set

Local Institution - 0138, Taipei, Not set

Local Institution - 0140, Taipei, Not set

Local Institution - 0310, Taipei, Not set

Local Institution - 0141, Taoyuan city, Not set

Local Institution - 0266, Middlesborough, Cleveland

Local Institution - 0098, London, Greater London

Local Institution - 0099, Southampton, Hampshire

Local Institution - 0118, Leicester, Leicestershire

Local Institution - 0265, Birmingham, Not set

Local Institution - 0051, Cambridgeshire, Not set

Local Institution - 0109, Edinburgh, Not set

Local Institution - 0097, London, Not set

Local Institution - 0050, London, Not set

Local Institution - 0119, Surrey, Not set

Conditions: Non-Small Cell Lung Cancer

Learn More ›

A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial

NCT02057380

Completed

The purpose of this study is to provide access to continued treatment for subjects who participated in other Astellas sponsored trials and for whom the investigator feels the subject may benefit from continued treatment.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/15/2024

Locations: Site US10004, La Jolla, California +11 locations

Conditions: Advanced Solid Tumors

Learn More ›

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

NCT04380636

Active Not Recruiting

The purpose of this study is to assess the efficacy and safety of pembrolizumab in combination with concurrent chemoradiation therapy followed by either pembrolizumab with olaparib placebo (Arm 1) or with olaparib (Arm 2) compared to concurrent chemoradiation therapy followed by durvalumab (Arm 3) in participants with unresectable, locally advanced NSCLC. Arms 1 and 2 will be studied in a double-blind design and Arm 3 will be open-label. The primary hypotheses are: 1. Pembrolizumab with concurr... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/15/2024

Locations: University of South Alabama, Mitchell Cancer Institute ( Site 0003), Mobile, Alabama +204 locations

University of South Alabama, Mitchell Cancer Institute ( Site 0003), Mobile, Alabama

St. Bernards Medical Center ( Site 0089), Jonesboro, Arkansas

St Joseph Heritage Healthcare-Oncology ( Site 0088), Fullerton, California

Long Beach Memorial Medical Center ( Site 0006), Long Beach, California

UCLA Hematology/Oncology - Santa Monica ( Site 0013), Los Angeles, California

St. Joseph Heritage Healthcare Local Lab ( Site 0011), Santa Rosa, California

Torrance Memorial Physician Network / Cancer Center ( Site 0093), Torrance, California

Memorial Regional Hospital-Memorial Cancer Institute ( Site 0095), Hollywood, Florida

Miami VA Healthcare System ( Site 0024), Miami, Florida

Mid Florida Hematology and Oncology Center ( Site 0022), Orange City, Florida

Orlando Health, UF Health Cancer Center Inc ( Site 0092), Orlando, Florida

Fort Wayne Medical Oncology and Hematology ( Site 0094), Fort Wayne, Indiana

Parkview Research Center ( Site 0032), Fort Wayne, Indiana

Franciscan Health Lafayette East ( Site 0031), Lafayette, Indiana

University of Kentucky ( Site 0096), Lexington, Kentucky

Norton Brownsboro Hospital-Norton Cancer Institute - Brownsboro ( Site 0035), Louisville, Kentucky

Pikeville Medical Center ( Site 0036), Pikeville, Kentucky

Massachusetts General Hospital ( Site 0038), Boston, Massachusetts

Henry Ford Hospital ( Site 0045), Detroit, Michigan

VA St. Louis Health Care System ( Site 0047), Saint Louis, Missouri

Washington University Siteman Cancer Center ( Site 0046), Saint Louis, Missouri

CHI Health St. Francis ( Site 0053), Grand Island, Nebraska

Rutgers Cancer Institute of New Jersey ( Site 0054), New Brunswick, New Jersey

The Valley Hospital ( Site 0056), Paramus, New Jersey

Montefiore Einstein Center ( Site 0083), Bronx, New York

Novant Health Presbyterian ( Site 0081), Charlotte, North Carolina

Duke University Medical Center ( Site 0050), Durham, North Carolina

Piedmont Hematology-Oncology Associates ( Site 0080), Winston-Salem, North Carolina

The Lindner Center for Research and Education at The Christ Hospital ( Site 0060), Cincinnati, Ohio

Fox Chase Cancer Center ( Site 0063), Philadelphia, Pennsylvania

Sanford Cancer Center Oncology Clinic ( Site 0066), Sioux Falls, South Dakota

Veterans Affairs Puget Sound Health Care System [Seattle, WA] ( Site 0075), Seattle, Washington

Cancer Care Northwest ( Site 0074), Spokane Valley, Washington

Instituto Médico Río Cuarto ( Site 4003), Río Cuarto, Cordoba

Clinica Adventista Belgrano-Oncology ( Site 4002), Caba, Not set

Queen Elizabeth II Health Sciences Centre ( Site 0100), Halifax, Nova Scotia

Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0102), Montreal, Quebec

CIUSSS Ouest de l Ile - St-Mary s Hospital ( Site 0108), Montreal, Quebec

McGill University Health Center - Research Institute ( Site 0114), Montreal, Quebec

Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0, Quebec, Not set

Centro Investigación del Cáncer James Lind ( Site 0202), Temuco, Araucania

OrlandiOncologia ( Site 0201), Santiago, Region M. De Santiago

Bradfordhill ( Site 0200), Santiago, Region M. De Santiago

Oncocentro ( Site 0203), Vina del Mar, Valparaiso

Bradford Hill Norte ( Site 0204), Antofagasta, Not set

Beijing Cancer Hospital ( Site 3224), Beijing, Beijing

Peking Union Medical College Hospital ( Site 3201), Beijing, Beijing

Cancer Hospital Chinese Academy of Medical Sciences ( Site 3213), Beijing, Beijing

Beijing Cancer Hospital ( Site 3212), Beijing, Beijing

Daping Hospital,Third Military Medical University ( Site 3235), Chongqing, Chongqing

Fujian Provincial Cancer Hospital ( Site 3226), Fuzhou, Fujian

The First Affiliated Hospital of Xiamen University ( Site 3219), Xiamen, Fujian

Peking University Shenzhen Hospital ( Site 3216), Shenzhen, Guangdong

Cancer Hospital Chinese Academy Of Medical Sciences. Shenzhen Center ( Site 3200), Shenzhen, Guangdong

Henan Cancer Hospital ( Site 3205), Zhengzhou, Henan

Wuhan Union Hospital ( Site 3222), Wuhan, Hubei

Hubei Cancer Hospital ( Site 3218), Wuhan, Hubei

Hunan Cancer Hospital ( Site 3238), Changsha, Hunan

Xiangya Hospital of Central South University ( Site 3637), Changsha, Hunan

Second Xiangya Hospital of Central-South University ( Site 3227), Changsha, Hunan

Hunan Cancer Hospital ( Site 3225), Changsha, Hunan

Jiangsu Cancer Hospital ( Site 3234), Nanjing, Jiangsu

The Second Affiliated Hospital of Nanchang University ( Site 3206), Nanchang, Jiangxi

Jilin Cancer Hospital ( Site 3230), Changchun, Jilin

Shanghai Chest Hospital ( Site 3207), Shangai, Shanghai

Zhongshan Hospital Fudan University ( Site 3220), Shanghai, Shanghai

Shanghai Pulmonary Hospital ( Site 3203), Shanghai, Shanghai

West China Hospital of Sichuan University ( Site 3202), Chengdu, Sichuan

Tianjin Medical University Cancer Institute & Hospital ( Site 3204), Tianjin, Tianjin

The 1st Affil Hosp of College of Medicine, Zhejiang Univ ( Site 3232), Hangzhou, Zhejiang

Masarykuv onkologicky ustav ( Site 2206), Brno, Brno-mesto

Fakultni nemocnice Ostrava ( Site 2201), Ostrava, Ostrava Mesto

Fakultni nemocnice Kralovske Vinohrady-Radioterapeuticka a onkologicka klinika ( Site 2200), PRague, Praha 10

Fakultni nemocnice v Motole ( Site 2210), Praha, Praha, Hlavni Mesto

Nemocnice Na Plesi s.r.o. ( Site 2202), Nova Ves pod Plesi, Pribram

Krajska nemocnice Liberec, a.s. ( Site 2209), Liberec, Not set

Vseobecna fakultni nemocnice v Praze ( Site 2208), Praha 2, Not set

Nemocnice Na Bulovce ( Site 2205), Praha 8, Not set

North Estonia Medical Centre Foundation ( Site 1601), Tallin, Harjumaa

Tartu University Hospital ( Site 1600), Tartu, Tartumaa

Clinique Clairval ( Site 0802), Marseille, Bouches-du-Rhone

C.H.R.U. de Brest - Hopital Morvan ( Site 0806), Brest, Bretagne

Centre Hospitalier Annecy Genevois ( Site 0811), Epagny Metz Tessy, Haute-Savoie

Clinique Teissier Groupe ( Site 0808), Valenciennes, Nord

Hopital Avicenne ( Site 0803), Bobigny, Seine-Saint-Denis

Clinique de l'Europe-Service de pneumologie ( Site 0816), Amiens, Somme

H.I.A. Sainte-Anne ( Site 0815), Toulon, Var

CHD Vendee ( Site 0807), La Roche sur Yon, Vendee

Universitätsmedizin Göttingen - Georg-August-Universität ( Site 0917), Göttingen, Niedersachsen

Johannes Wesling Klinikum Minden ( Site 0908), Minden, Nordrhein-Westfalen

GEHO Muenster ( Site 0910), Muenster, Nordrhein-Westfalen

Johanna Etienne Hospital-Klinik für Onkologie ( Site 0916), Neuss, Nordrhein-Westfalen

LungenClinic Grosshansdorf GmbH ( Site 0901), Grosshansdorf, Schleswig-Holstein

Zentralklinik Bad Berka GmbH ( Site 0905), Bad Berka, Thuringen

Universitaetsklinikum Jena ( Site 0911), Jena, Thuringen

Charite-Universitaetsmedizin Berlin Campus Virchow-Klinikum ( Site 0900), Berlin, Not set

Katholisches Marienkrankenhaus gGmbH ( Site 0902), Hamburg, Not set

Bacs-Kiskun Megyei Korhaz-Onkoradiologiai Kozpont ( Site 2302), Kecskemét, Bacs-Kiskun

Bekes Megyei Kozponti Korhaz - Pandy Kalman Tagkorhaza ( Site 2303), Gyula, Bekes

Petz Aladar Megyei Oktato Korhaz ( Site 2306), Gyor, Gyor-Moson-Sopron

Orszagos Koranyi Pulmonologiai Intezet ( Site 2305), Budapest, Not set

Országos Korányi Pulmonológiai Intézet-VI. Tüdöbelosztály és Bronchológia ( Site 2309), Budapest, Not set

Azienda Ospedaliera Umberto I- Torrette ( Site 1009), Torrette, Ancona

Azienda Ospedaliero Universitaria Careggi ( Site 1001), Florence, Firenze

Istituto Clinico Humanitas Research Hospital ( Site 1000), Rozzano, Lombardia

Azienda Ospedaliera Vito Fazzi ( Site 1003), Lecce, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 1008), Milano, Not set

Policlinico di Modena ( Site 1007), Modena, Not set

Policlinico Agostino Gemelli ( Site 1002), Roma, Not set

A.O.U. Santa Maria della Misericordia di Udine ( Site 1004), Udine, Not set

Kurume University Hospital ( Site 3112), Kurume, Fukuoka

Kobe Minimally Invasive Cancer Center ( Site 3100), Kobe, Hyogo

Kanagawa Cancer Center ( Site 3101), Yokohama, Kanagawa

Kansai Medical University Hospital ( Site 3103), Hirakata, Osaka

Osaka Medical and Pharmaceutical University Hospital ( Site 3110), Takatsuki, Osaka

National Hospital Organization Kyushu Cancer Center ( Site 3104), Fukuoka, Not set

Niigata Cancer Center Hospital ( Site 3109), Niigata, Not set

Osaka International Cancer Institute ( Site 3106), Osaka, Not set

Juntendo University Hospital ( Site 3111), Tokyo, Not set

Tokyo Metropolitan Komagome Hospital ( Site 3108), Tokyo, Not set

The Cancer Institute Hospital of JFCR ( Site 3107), Tokyo, Not set

Showa University Hospital ( Site 3105), Tokyo, Not set

Chungbuk National University Hospital ( Site 2802), Cheongju-si, Chungbuk

National Cancer Center ( Site 2800), Goyang-si, Kyonggi-do

The Catholic University of Korea St. Vincent s Hospital ( Site 2805), Gyeonggi-do, Kyonggi-do

Seoul National University Bundang Hospital ( Site 2801), Seongnam-si, Kyonggi-do

Ajou University Hospital ( Site 2803), Suwon-si, Kyonggi-do

Gyeongsang National University Hospital ( Site 2804), Jinju-si, Kyongsangnam-do

Keimyung University Dongsan Hospital ( Site 2807), Daegu, Taegu-Kwangyokshi

Kangbuk Samsung Hospital ( Site 2806), Seoul, Not set

Severance Hospital Yonsei University Health System ( Site 2808), Seoul, Not set

Pauls Stradins Clinical University Hospital ( Site 1501), Riga, Not set

Riga East Clinical University Hospital ( Site 1500), Riga, Not set

Hospital of Lithuanian University of Health Sciences Kauno klinikos-Pulmonology ( Site 4201), Kaunas, Kauno Apskritis

National Cancer Institute-Department of Thoracic Surgery and Oncology ( Site 4200), Vilnius, Vilniaus Miestas

Hospital Civil de Guadalajara Fray Antonio Alcalde ( Site 0500), Guadalajara, Jalisco

Hospital Universitario "Dr. Jose Eleuterio Gonzalez" ( Site 0508), Monterrey, Nuevo Leon

CLIMERS Clinical Medical Research ( Site 0506), Orizaba, Veracruz

Instituto Nacional de Cancerologia ( Site 0502), Tlalpan, Not set

Akershus Universitetssykehus HF ( Site 1106), Lorenskog, Akershus

Vestre Viken HF Drammen Sykehus ( Site 1101), Drammen, Buskerud

Sykehuset Oestfold ( Site 1107), Gralum, Ostfold

Helse Stavanger HF Stavanger Universitetssjukehus ( Site 1103), Stavanger, Rogaland

Oslo Universitetssykehus HF. Ulleval ( Site 1100), Oslo, Not set

Hospital Nacional Carlos Alberto Seguin Escobedo ESSALUD ( Site 0604), Arequipa, Ariqipa

Oncosalud ( Site 0605), Lima, Muni Metro De Lima

Detecta Clínica ( Site 0607), Surquillo, Muni Metro De Lima

IPOR Instituto Peruano de Oncología & Radioterapia ( Site 0606), Lima, Not set

Clinica San Gabriel ( Site 0601), Lima, Not set

Hospital Nacional Cayetano Heredia ( Site 0602), Lima, Not set

Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 2404), Siedlce, Mazowieckie

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warszawa, Mazowieckie

Szpital Morski im. PCK. Szpitale Pomorskie Sp. Z o.o ( Site 2400), Gdynia, Pomorskie

SPZOZ MSWIA z Warminsko-Mazurskim Centrum Onkologii w Olsztynie ( Site 2401), Olsztyn, Warminsko-mazurskie

Spitalul Universitar de Urgenta Bucuresti ( Site 2508), Bucharest, Bucuresti

Gral Medical SRL-Medical Oncology ( Site 2511), București, Bucuresti

Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 2506), Cluj Napoca, Cluj

S.C. Radiotherapy Center Cluj S.R.L ( Site 2503), Comuna Floresti, Cluj

Centrul de Oncologie "Sfântul Nectarie"-Medical Oncology ( Site 2510), Craiova, Dolj

Radiology Therapeutic Center-Oncology ( Site 2502), Otopeni, Ilfov

Policlinica Oncomed SRL ( Site 2504), Timisoara, Timis

S C Oncocenter Oncologie Clinica S R L-Medical Oncology ( Site 2509), Timișoara, Timis

S.C.Focus Lab Plus S.R.L ( Site 2500), Bucuresti, Not set

Spitalul Clinic Judetean De Urgenta Constanta ( Site 2501), Constanta, Not set

Institutul Regional de Oncologie Iasi ( Site 2505), Iasi, Not set

Chelyabinsk Regional Clinical Oncological Dispensary ( Site 1913), Chelyabinsk, Chelyabinskaya Oblast

MSROI named after P.A. Hertsen branch of FSBI NMRC Radiology ( Site 1903), Moscow, Moskva

Nizhniy Novgorod Region Oncology Dispensary ( Site 1914), Nizhniy Novgorod, Nizhegorodskaya Oblast

Scientific Research Oncology Institute n.a. N.N.Petrov ( Site 1905), Saint-Petersburg, Sankt-Peterburg

Medical institute named after Berezin Sergey ( Site 1906), St. Petersburg, Sankt-Peterburg

Sverdlovsk Regional Oncology Hospital ( Site 1909), Ekaterinburg, Sverdlovskaya Oblast

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1911), Kazan, Tatarstan, Respublika

Yaroslavl Regional SBIH Clinical Oncology Hospital ( Site 1910), Yaroslavl, Yaroslavskaya Oblast

Hospital Universitario Puerta de Hierro (Majadahonda) ( Site 1202), Majadahonda, Madrid

Hospital Universitario Quiron Madrid ( Site 1200), Pozuelo de Alarcon, Madrid

H.R.U Málaga - Hospital General ( Site 1206), Málaga, Malaga

H.U. Vall de Hebron ( Site 1201), Barcelona, Not set

Hospital Clinic de Barcelona ( Site 1204), Barcelona, Not set

Hospital Universitario Virgen Macarena ( Site 1205), Sevilla, Not set

Hospital Universitario La Fe ( Site 1203), Valencia, Not set

Chulalongkorn University ( Site 3003), Bangkok, Krung Thep Maha Nakhon

Ramathibodi Hospital. ( Site 3000), Bangkok, Krung Thep Maha Nakhon

Chiang Mai University Maharaj Nakorn Chiang Mai Hospital ( Site 3001), Chiang Mai, Not set

Srinagarind Hospital. Khon Kaen University ( Site 3002), Khon Kaen, Not set

Ankara Bilkent Sehir Hastanesi ( Site 2002), Ankara, Adana

Memorial Ankara Hastanesi ( Site 2006), Ankara, Not set

Istanbul Uni. Cerrahpasa Tip Fakultesi ( Site 2000), Istanbul, Not set

Medipol Universite Hastanesi ( Site 2003), Istanbul, Not set

Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi-oncology ( Site 2001), Istanbul, Not set

Ege University Medical Faculty ( Site 2005), Izmir, Not set

Medical center Medikal Plaza of Ecodnipro LLC ( Site 2107), Dnipro, Dnipropetrovska Oblast

SOGrigoriev Inst for Med Radiolgy and Oncology of NAMS of Ukraine-Clinical oncology and hematology (, Kharkiv, Kharkivska Oblast

Communal nonprofit enterprise "Kherson Regional Oncology Dispensary" of Kherson Regional Council (, Antonivka Village, Khersonska Oblast

LLC Ukrainian Center of Tomotherapy ( Site 2105), Kropyvnytskyi, Kirovohradska Oblast

Medical Center of Yuriy Spizhenko LLC.-Clinical Trial ( Site 2104), Kapitanivka Village, Kyivska Oblast

SNPE National Cancer Institute ( Site 2101), Kyiv, Kyivska Oblast

Medical Center Verum ( Site 2106), Kyiv, Kyivska Oblast

Kyiv City Clinical Oncology Center ( Site 2100), Kyiv, Not set

Weston Park Hospital ( Site 1406), Sheffield, Derbyshire

University College Hospital NHS Foundation Trust ( Site 1403), London-Camden, London, City Of

Guys and St Thomas NHS Foundation Trust ( Site 1410), London, London, City Of

Royal Marsden Hospital (Sutton) ( Site 1407), London, Surrey

Southampton General Hospital ( Site 1400), Southampton, Worcestershire

Leeds Teaching Hospitals NHS Trust ( Site 1401), Leeds, Not set

Christie NHS Foundation Trust ( Site 1409), Manchester, Not set

Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung

Learn More ›

Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion

NCT04794699

Recruiting

This is a Phase 1, open-label, multicenter, dose escalation and expansion study of the safety, PK, PD, and preliminary anti-tumor activity of IDE397 as a single agent and in combination with other anticancer agents including taxanes (docetaxel, paclitaxel), or sacituzumab govitecan (SG), in adult patients with selected advanced or metastatic MTAP-deleted advanced solid tumors who are unresponsive to standard of care therapy. IDE397 is a small molecule inhibitor of methionine adenosyltransferase... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/15/2024

Locations: Honor Health Research Institute, Scottsdale, Arizona +37 locations

Honor Health Research Institute, Scottsdale, Arizona

University of Arkansas for Medical Sciences, Little Rock, Arkansas

City of Hope, Duarte, California

Providence Medical Group, Santa Rosa, California

Advent Health, Celebration, Florida

Orlando Health Cancer Institute, Orlando, Florida

Indiana University Health Hospital, Indianapolis, Indiana

Markey Cancer Center, Lexington, Kentucky

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland

Dana Farber Cancer Institute, Boston, Massachusetts

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan

Columbia University Medical Center - Herbert Irving Pavilion, New York, New York

Weill Cornell Medical College, New York, New York

Stephenson Cancer Center, Oklahoma City, Oklahoma

LifeSpan - Brown University, Providence, Rhode Island

SCRI Oncology Partners, Nashville, Tennessee

MD Anderson, Houston, Texas

Next Oncology, San Antonio, Texas

Swedish Cancer Institute, Seattle, Washington

The Kinghorn Cancer Centre, St Vincent's Health Network Sydney, Darlinghurst, New South Wales

Southern Oncology Clinical Research Unit, Bedford Park, South Australia

Institut Bergonie, Bordeaux, Bordeaux Cedex

Institut Claudius Regaud - IUCT-Oncopole, Toulouse, Cedex 9

Hôpital Timone, Marseille, Not set

Centre Eugène Marquis, Rennes, Not set

Universitaetsklinikum Hamburg-Eppendorf (UKE), Hamburg, Not set

Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-Do

National Cancer Center, Goyang-si, Gyeonggi

CHA University - Bundang Medical Center, Seongnam-si, Gyeonggi

Sevrance Hospital, Seoul, Not set

Asan Medical Center, Seoul, Not set

Vall Hebron Institute of Oncology, Barcelona, Not set

Hospital Universitario 12 de Octubre (H12O), Madrid, Not set

START Madrid-HM - Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Not set

NEXT Madrid, Universitary Hospital QuironSAlud, Madrid, Not set

Instituto Valenciano de Oncología (IVO), Valencia, Not set

National Cheng Kung University Hospital, Tainan, Not set

National Taiwan University Hospital, Taipei, Not set

Conditions: Solid Tumor

Learn More ›

Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

NCT03740165

Active Not Recruiting

The purpose of this study is to assess the efficacy and safety of treatment with carboplatin/paclitaxel\* PLUS pembrolizumab (MK-3475) and maintenance olaparib (MK-7339) in women with epithelial ovarian cancer (EOC), fallopian tube cancer, or primary peritoneal cancer. The primary study hypotheses are that the combination of pembrolizumab plus carboplatin/paclitaxel\* followed by continued pembrolizumab and maintenance olaparib is superior to carboplatin/paclitaxel alone with respect to Progres... Read More

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

11/15/2024

Locations: University of Alabama at Birmingham (UAB) ( Site 0036), Birmingham, Alabama +226 locations

University of Alabama at Birmingham (UAB) ( Site 0036), Birmingham, Alabama

University of Arizona Cancer Center ( Site 0074), Tucson, Arizona

Disney Family Cancer Center ( Site 0042), Burbank, California

Kaiser Permanente Oncology Clinical Trial -Oakland ( Site 0077), Oakland, California

Kaiser Permanente Oncology Clinical Trials-Roseville ( Site 0084), Roseville, California

Kaiser Permanente Oncology Clinical Trials-Sacramento ( Site 0083), Sacramento, California

Kaiser Permanente Oncology Clinical Trial - San Francisco ( Site 0078), San Francisco, California

Kaiser Permanente Oncology Clinical Trial - Santa Clara ( Site 0079), Santa Clara, California

Kaiser Permanente N. CA Regional Oncology Clinical Trials ( Site 0008), Vallejo, California

Kaiser Permanente Oncology Clinical Trial - Walnut Creek ( Site 0080), Walnut Creek, California

Smilow Cancer Center at Yale-New Haven ( Site 0057), New Haven, Connecticut

Sarasota Memorial Hospital ( Site 0023), Sarasota, Florida

Emory School of Medicine ( Site 0053), Atlanta, Georgia

Northeast Georgia Medical Center ( Site 0029), Gainesville, Georgia

Memorial Health University Medical Center ( Site 0011), Savannah, Georgia

Rush University Medical Center ( Site 0019), Chicago, Illinois

University of Chicago ( Site 0049), Chicago, Illinois

Dr. Sudarshan K. Sharma, LTD ( Site 0061), Hinsdale, Illinois

Saint Vincent Hospital and Health Center ( Site 0012), Indianapolis, Indiana

University of Iowa Hospital and Clinics ( Site 0005), Iowa City, Iowa

University of Kentucky ( Site 0045), Lexington, Kentucky

Weinberg Cancer Institute at Franklin Square ( Site 0035), Baltimore, Maryland

Saint Dominic - Jackson Memorial Hospital ( Site 0072), Jackson, Mississippi

Washington University - School of Medicine ( Site 0062), Saint Louis, Missouri

Nebraska Methodist Hospital ( Site 0063), Omaha, Nebraska

Dartmouth Hitchcock Medical Center ( Site 0024), Lebanon, New Hampshire

MD Anderson Cancer Center at Cooper ( Site 0067), Camden, New Jersey

Holy Name Medical Center ( Site 0037), Teaneck, New Jersey

Northwell Health- Monter Cancer Center ( Site 0075), Lake Success, New York

Sanford Roger Maris Cancer Center ( Site 0082), Fargo, North Dakota

Miami Valley Hospital [Dayton, OH] ( Site 0073), Centerville, Ohio

Oncology/Hematology Care Clinical Trials, LLC ( Site 8001), Cincinnati, Ohio

The Bing Cancer Center ( Site 0044), Columbus, Ohio

OSU Wexner Medical Center ( Site 0076), Hilliard, Ohio

Women and Infants Hospital [Providence, RI] ( Site 0039), Providence, Rhode Island

Sanford Gynecology Oncology ( Site 0004), Sioux Falls, South Dakota

Texas Oncology, P.A. - Bedford ( Site 8005), Bedford, Texas

Texas Oncology-Dallas Presbyterian Hospital ( Site 8004), Dallas, Texas

Parkland Hospital ( Site 0081), Dallas, Texas

UT Southwestern Medical Center ( Site 0046), Dallas, Texas

Texas Oncology, P.A. Texas Oncology-Tyler ( Site 8006), Tyler, Texas

Virginia Cancer Specialists, PC ( Site 8003), Gainesville, Virginia

MEDICAL COLLEGE OF WISCONSIN ( Site 0064), Milwaukee, Wisconsin

St George Hospital ( Site 2207), Kogarah, New South Wales

Cairns and Hinterland Hospital and Health Service ( Site 2201), Cairns, Queensland

Ballarat Health Services ( Site 2202), Ballarat, Victoria

Monash Health ( Site 2204), Clayton, Victoria

Sunshine Hospital. ( Site 2205), St Albans, Victoria

Imelda Ziekenhuis Bonheiden ( Site 0301), Bonheiden, Antwerpen

UZ Leuven Campus Gasthuisberg ( Site 0306), Leuven, Antwerpen

Cliniques Universitaires Saint-Luc ( Site 0312), Brussels, Bruxelles-Capitale, Region De

Grand Hopital de Charleroi ( Site 0302), Charleroi, Hainaut

CHU de Liege ( Site 0310), Liège, Liege

Jessa Ziekenhuis ( Site 0309), Hasselt, Limburg

Centre Hospitalier de l'Ardenne ( Site 0303), Libramont, Luxembourg

AZ Maria Middelares Gent ( Site 0300), Gent, Oost-Vlaanderen

UZ Gent ( Site 0307), Gent, Oost-Vlaanderen

Instituto do Cancer do Ceara ( Site 2707), Fortaleza, Ceara

Hospital Araujo Jorge Associacao de Combate ao Cancer de Goias ( Site 2708), Goiania, Goias

Hospital Erasto Gaertner ( Site 2716), Curitiba, Parana

Hospital de Caridade de Ijui ( Site 2712), Ijui, Rio Grande Do Sul

Hospital Bruno Born ( Site 2704), Lajeado, Rio Grande Do Sul

Hospital Nossa Senhora Da Conceicao ( Site 2703), Porto Alegre, Rio Grande Do Sul

Instituto Nacional de Cancer Hospital do Cancer II ( Site 2700), Rio de Janeiro, Not set

Instituto do Cancer do Estado de Sao Paulo - ICESP ( Site 2714), Sao Paulo, Not set

Clinica de Pesquisas e Ctro de Estudos Onc. Ginecol. e Mamaria Ltda ( Site 2706), Sao Paulo, Not set

Real e Benemerita Associacao Portuguesa de Beneficencia ( Site 2710), Sao Paulo, Not set

Tom Baker Cancer Centre ( Site 0200), Calgary, Alberta

Kingston Health Sciences Centre ( Site 0207), Kingston, Ontario

The Credit Valley Hospital ( Site 0206), Mississauga, Ontario

Princess Margaret Hospital.. ( Site 0202), Toronto, Ontario

CIUSSS du Saguenay-Lac-St-Jean ( Site 0218), Chicoutimi, Quebec

CIUSSS de l Est de L Ile de Montreal - Hopital Maisonneuve-Rosemont ( Site 0219), Montreal, Quebec

Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0208), Montreal, Quebec

Royal Victoria Hospital McGill University Health Centre ( Site 0211), Montreal, Quebec

Centro Investigación del Cáncer James Lind ( Site 2810), Temuco, Araucania

Centro de Investigacion y desarrollo Oncologico SpA - CIDO SpA ( Site 2808), Temuco, Araucania

Fundacion Arturo Lopez Perez FALP ( Site 2800), Santiago, Region M. De Santiago

Sociedad Oncovida S.A. ( Site 2807), Santiago, Region M. De Santiago

Iram Cancer Research ( Site 2809), Santiago, Region M. De Santiago

Pontificia Universidad Catolica de Chile ( Site 2805), Santiago, Region M. De Santiago

Oncocentro ( Site 2801), Vina del Mar, Valparaiso

Centro Oncologico Antofagasta ( Site 2804), Antofagasta, Not set

Biomelab S A S ( Site 2900), Barranquilla, Atlantico

Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 2913), Valledupar, Cesar

Oncomedica S.A. ( Site 2911), Monteria, Cordoba

Instituto Nacional de Cancerologia E.S.E ( Site 2910), Bogota, Distrito Capital De Bogota

Clinica Colsanitas S.A. Sede Clinica Universitaria Colombia ( Site 2912), Bogota, Distrito Capital De Bogota

Centro Medico Imbanaco de Cali S.A ( Site 2909), Cali, Valle Del Cauca

Hemato Oncologos S.A. ( Site 2906), Cali, Valle Del Cauca

Fakultni nemocnice Brno ( Site 0404), Brno, Brno-mesto

Fakultni nemocnice Ostrava ( Site 0403), Ostrava-Poruba, Moravskoslezsky Kraj

Vseobecna fakultni nemocnice v Praze ( Site 0400), Praha, Praha, Hlavni Mesto

Nemocnice Na Bulovce ( Site 0401), Praha, Praha, Hlavni Mesto

Fakultni nemocnice Olomouc ( Site 0402), Olomouc, Not set

Hopital Prive Jean Mermoz ( Site 0607), Lyon, Auvergne

Centre Paul Strauss ( Site 0615), Strasbourg, Bas-Rhin

Hopital de la Timone ( Site 0617), Marseille, Bouches-du-Rhone

CHU de Brest -Site Hopital Morvan ( Site 0616), Brest, Bretagne

Institut de Cancerologie du Gard - CHU Caremeau ( Site 0610), Nimes, Gard

Institut de Cancerologie Lucien Neuwirth ( Site 0613), Saint-Priest-en-Jarez, Loire

Centre D Oncologie de Gentilly ( Site 0609), Nancy, Meurthe-et-Moselle

Institut Gustave Roussy ( Site 0600), Villejuif, Val-de-Marne

Hopital Tenon ( Site 0612), Paris, Not set

Marienhospital Stuttgart Vincenz von Paul Kliniken gGmbH ( Site 0707), Stuttgart, Baden-Wurttemberg

Klinikum Rechts der Isar. Technischen Universitaet Muenchen ( Site 0710), Muenchen, Bayern

Uniklinik RWTH Aachen ( Site 0718), Aachen, Nordrhein-Westfalen

Gynaekologisches Zentrum ( Site 0712), Bonn, Nordrhein-Westfalen

Klinikum Dortmund gGmbH ( Site 0717), Dortmund, Nordrhein-Westfalen

Universitaetsklinikum Duesseldorf ( Site 0704), Duesseldorf, Nordrhein-Westfalen

HELIOS Klinikum Krefeld ( Site 0715), Krefeld, Nordrhein-Westfalen

Universitaetsklinikum Muenster ( Site 0720), Muenster, Nordrhein-Westfalen

Caritas Klinikum Saarbruecken St. Theresia ( Site 0702), Saarbruecken, Saarland

Klinikum Chemnitz gGmbH ( Site 0711), Chemnitz, Sachsen

Staedtisches Krankenhaus Kiel GmbH ( Site 0709), Kiel, Schleswig-Holstein

Charite Campus Virchow-Klinikum - CVK ( Site 0700), Berlin, Not set

Pecsi Tudomanyegyetem Klinikai Kozpont ( Site 0805), Pecs, Baranya

Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz ( Site 0802), Miskolc, Borsod-Abauj-Zemplen

Orszagos Onkologiai Intezet ( Site 0800), Budapest, Not set

Uzsoki Utcai Korhaz ( Site 0803), Budapest, Not set

Debreceni Egyetem Klinikai Kozpont ( Site 0801), Debrecen, Not set

Soroka Medical Center ( Site 1006), Beer-Sheva, Not set

Hillel Yaffe Medical Center ( Site 1011), Hadera, Not set

Carmel Medical Center ( Site 1007), Haifa, Not set

Rambam Medical Center ( Site 1002), Haifa, Not set

Edith Wolfson Medical Center ( Site 1003), Holon, Not set

Shaare Zedek Medical Center ( Site 1005), Jerusalem, Not set

Rabin Medical Center ( Site 1004), Petah Tikva, Not set

Chaim Sheba Medical Center ( Site 1000), Ramat Gan, Not set

Sourasky Medical Center ( Site 1001), Tel Aviv, Not set

IRCCS Giovanni Paolo II. Ospedale Oncologico ( Site 1108), Bari, Abruzzo

Istituto Europeo di Oncologia ( Site 1100), Milano, Lombardia

A.O.U. Citta della Salute e della Scienza di Torino ( Site 1104), Torino, Piemonte

Istituto Oncologico Veneto IRCCS ( Site 1113), Padova, Veneto

Sacro Cuore di Gesu Fatebenefratelli ( Site 1112), Benevento, Not set

Ospedale Cannizzaro ( Site 1110), Catania, Not set

ASST Lecco. Ospedale A. Manzoni ( Site 1101), Lecco, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 1115), Milano, Not set

A.O.U. Federico II di Napoli ( Site 1107), Napoli, Not set

Azienda Ospedaliera Policlinico Umberto I ( Site 1111), Roma, Not set

Policlinico Universitario Gemelli ( Site 1105), Roma, Not set

Presidio Ospedaliero Santa Chiara ( Site 1109), Trento, Not set

A.O. Univ. S. M. della Misericordia ( Site 1114), Udine, Not set

National Cancer Center Hospital East ( Site 2602), Kashiwa, Chiba

National Hospital Organization Shikoku Cancer Center ( Site 2601), Matsuyama, Ehime

Ehime University Hospital ( Site 2600), Toon, Ehime

Gunma Prefectural Cancer Center ( Site 2609), Ota, Gunma

Hokkaido University Hospital ( Site 2607), Sapporo, Hokkaido

Iwate Medical University Hospital ( Site 2606), Shiwa-gun, Iwate

St. Marianna University School of Medicine Hospital ( Site 2613), Kawasaki, Kanagawa

University of the Ryukyus Hospital ( Site 2616), Nakagami-gun, Okinawa

Saitama Medical University International Medical Center ( Site 2604), Hidaka, Saitama

Saitama Cancer Center ( Site 2614), Kitaadachi-gun, Saitama

National Defense Medical College Hospital ( Site 2608), Tokorozawa, Saitama

Kyorin University Hospital ( Site 2610), Mitaka, Tokyo

Kagoshima City Hospital ( Site 2612), Kagoshima, Not set

Niigata Cancer Center Hospital ( Site 2618), Niigata, Not set

Osaka International Cancer Institute ( Site 2617), Osaka, Not set

National Cancer Center Hospital ( Site 2605), Tokyo, Not set

Seoul National University Bundang Hospital ( Site 2404), Seongnam-si, Kyonggi-do

Seoul National University Hospital ( Site 2403), Seoul, Not set

Severance Hospital Yonsei University Health System ( Site 2400), Seoul, Not set

Asan Medical Center ( Site 2402), Seoul, Not set

Samsung Medical Center ( Site 2401), Seoul, Not set

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warszawa, Mazowieckie

Bialostockie Centrum Onkologii ( Site 1412), Bialystok, Podlaskie

Szpitale Pomorskie Sp. z o.o. ( Site 1407), Gdynia, Pomorskie

Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 1406), Gliwice, Slaskie

Swietokrzyskie Centrum Onkologii SPZOZ ( Site 1410), Kielce, Swietokrzyskie

Szpital Kliniczny im. Przemienienia Panskiego Uniwersytetu Medycznego im. K. Marcinkowskiego w Pozna, Poznan, Wielkopolskie

Arkhangelsk Clinical Oncological Dispensary ( Site 1508), Arkhangelsk, Arkhangel Skaya Oblast

Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 1507), Ufa, Baskortostan, Respublika

A. Tsyb Medical Radiological Research Center ( Site 1513), Obninsk, Kaluzskaja Oblast

FSBI National Medical Oncology Research Center n.a. N.N. Blokhina ( Site 1500), Moscow, Moskva

FSCC of Special Types of Med. Care and Technologies ( Site 1503), Moscow, Moskva

Medical Rehabilitation Center ( Site 1502), Moscow, Moskva

City Clinical Oncology Center ( Site 1505), Saint Petersburg, Sankt-Peterburg

National Medical Research Center of Oncology N.A. N.N. Petrov ( Site 1504), Saint-Petersburg, Sankt-Peterburg

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1509), Kazan, Tatarstan, Respublika

Cancer Care Langenhoven Drive Oncology Centre ( Site 1701), Port Elizabeth, Eastern Cape

Groote Schuur Hospital ( Site 1704), Cape Town, Gauteng

Wits Clinical Research ( Site 1702), Johannesburg, Gauteng

Department of Medical Oncology ( Site 1703), Pretoria, Gauteng

Curo Oncology ( Site 1710), Pretoria, Gauteng

Wilgers Oncology Centre ( Site 1705), Pretoria, Gauteng

Little Company of Mary Hospital ( Site 1700), Pretoria, Gauteng

Sandton Oncology Medical Group PTY LTD ( Site 1712), Sandton, Gauteng

The Oncology Centre ( Site 1709), Durban, Kwazulu-Natal

Cancercare ( Site 1706), Cape Town, Western Cape

Outeniqua Cancercare Oncology Unit ( Site 1708), George, Western Cape

Cape Town Oncology Trials Pty Ltd ( Site 1707), Kraaifontein, Western Cape

Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals ( Site 1603), Hospitalet de Llobregat, Barcelona

Xarxa Assistencial Universitaria Manresa ( Site 1605), Manresa, Barcelona

Hospital de Terrassa ( Site 1606), Terrassa, Barcelona

Hospital Universitario de Donostia ( Site 1602), Donostia, Gipuzkoa

Complejo Hospitalario Universitario A Coruna. CHUAC ( Site 1608), A Coruna, La Coruna

Instituto Valenciano de Oncologia ( Site 1601), Valencia, Valenciana, Comunitat

Hospital General Universitario de Valencia ( Site 1610), Valencia, Valenciana, Comunitat

Hospital Provincial San Pedro de Alcantara ( Site 1607), Caceres, Not set

Hospital Universitario Lucus Augusti ( Site 1609), Lugo, Not set

Clinica Universitaria de Navarra ( Site 1600), Madrid, Not set

Hospital Universitario Virgen del Rocio ( Site 1604), Sevilla, Not set

Changhua Christian Hospital ( Site 2507), Changhua, Not set

China Medical University Hospital ( Site 2506), Taichung, Not set

Taichung Veterans General Hospital ( Site 2510), Taichung, Not set

National Cheng Kung University Hospital ( Site 2508), Tainan, Not set

National Taiwan University Hospital ( Site 2502), Taipei, Not set

MacKay Memorial Hospital ( Site 2500), Taipei, Not set

Taipei Veterans General Hospital ( Site 2503), Taipei, Not set

Linkou Chang Gung Memorial Hospital ( Site 2501), Taoyuan, Not set

Istanbul Acibadem University Atakent Hospital ( Site 1902), Kucukcekmece, Istanbul

Etlik Zubeyde Hanim Kadin Hastaliklari Egitim ve Arastirma Hastanesi ( Site 1903), Ankara, Not set

Ankara UTF Cebeci Arastırma ve Uygulama Hastanesi ( Site 1905), Ankara, Not set

Akdeniz Universitesi Tıp Fakultesi ( Site 1901), Antalya, Not set

Uludag Universitesi Tip Fakultesi ( Site 1904), Bursa, Not set

Istanbul Universitesi Istanbul Tip Fakultesi ( Site 1900), Istanbul, Not set

Bakirkoy Sadi Konuk Egitim ve Arastirma Hastanesi ( Site 1907), Istanbul, Not set

Medipol Universite Hastanesi ( Site 1909), Istanbul, Not set

Sakarya Universitesi Tip Fakultesi Hastanesi ( Site 1906), Sakarya, Not set

MI Precarpathian Clinical Oncology Center ( Site 2181), Ivano-Frankivsk, Ivano-Frankivska Oblast

Grigoriev Institute for medical Radiology NAMS of Ukraine ( Site 2180), Kharkiv, Kharkivska Oblast

Municipal non-profit Enterprise Khmelnytskyi Regional Antitu-Gynecological Oncology department, Poli, Khmelnytskyi, Khmelnytska Oblast

Lviv State Oncology Regional Treatment and Diagnostic Center ( Site 2170), Lviv, Lvivska Oblast

MI Odessa Regional Oncological Centre ( Site 2121), Odesa, Odeska Oblast

RMI - Sumy Regional Clinical Oncology Dispensary ( Site 2191), Sumy, Sumska Oblast

Central City Clinical Hospital ( Site 2150), Uzhgorod, Zakarpatska Oblast

Kyiv City Clinical Oncological Center ( Site 2140), Kyiv, Not set

Conditions: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms

Learn More ›

Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)

NCT04956692

Active Not Recruiting

The purpose of this study is to evaluate pembrolizumab (MK-3475) subcutaneous (SC) administration as the first-line therapy in the treatment of metastatic squamous and nonsquamous NSCLC by assessing the pharmacokinetics (PK), safety, and efficacy of pembrolizumab SC injection in combination with standard-of-care chemotherapy. The primary hypothesis of the study is Pembrolizumab SC is noninferior to pembrolizumab intravenous (IV) for Cycle 1 Area Under Curve (AUC) and Cycle 6 minimal concentratio... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/14/2024

Locations: St. Bernards Medical Center ( Site 0103), Jonesboro, Arkansas +125 locations

St. Bernards Medical Center ( Site 0103), Jonesboro, Arkansas

St Joseph Heritage Healthcare-Oncology ( Site 0102), Fullerton, California

Cancer Blood and Specialty Clinic ( Site 0105), Los Alamitos, California

PIH Health Hematology Medical Oncology ( Site 0106), Whittier, California

Holy Cross Hospital ( Site 0017), Fort Lauderdale, Florida

Memorial Regional Hospital-Memorial Cancer Institute ( Site 0104), Hollywood, Florida

Advent Health ( Site 0013), Orlando, Florida

Fort Wayne Medical Oncology and Hematology ( Site 0101), Fort Wayne, Indiana

Baptist Health Lexington ( Site 0099), Lexington, Kentucky

St Luke's Hospital - Kansas City ( Site 0033), Kansas City, Missouri

St. Vincent Frontier Cancer Center ( Site 0058), Billings, Montana

Montefiore Medical Center [Bronx, NY] ( Site 0040), Bronx, New York

The University of Tennessee Medical Center ( Site 0050), Knoxville, Tennessee

Tennessee Oncology ( Site 0051), Nashville, Tennessee

Oncology Consultants, PA ( Site 0052), Houston, Texas

Millennium Physicians - Oncology ( Site 0097), Houston, Texas

Oncology & Hematology Assoc. SW Virginia, Inc., DBA Blue Ridge Cancer Care ( Site 0100), Blacksburg, Virginia

West Virginia University ( Site 0056), Morgantown, West Virginia

HOSPITAL EVANGÉLICO DE CACHOEIRO DE ITAPEMIRIM ( Site 0307), Cachoeiro de Itapemirim, Espirito Santo

Hospital Sao Vicente de Paulo ( Site 0311), Passo Fundo, Rio Grande Do Sul

Instituto Joinvilense de Hematologia e Oncologia ( Site 0308), Joinville, Santa Catarina

Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto ( Site 0305), Sao Jose do Rio Preto, Sao Paulo

Núcleo de Pesquisa Clínica da Rede São Camilo ( Site 0304), São Paulo, Sao Paulo

Nouvel Hôpital Civil (NHC) ( Site 1018), Strasbourg, Bas-Rhin

CHU Limoges CHU Dupuytren ( Site 1011), Limoges, Haute-Vienne

Hôpital Foch ( Site 1019), Suresnes, Hauts-de-Seine

Institut Regional du Cancer de Montpellier - ICM ( Site 1003), Montpellier, Herault

Centre Hospitalier Sud Réunion ( Site 1020), Saint-Pierre, La Reunion

Hopital Guillaume & Rene Laennec ( Site 1007), Saint-Herblain, Loire-Atlantique

Centre Hospitalier de Pau ( Site 1016), Pau, Pyrenees-Atlantiques

CHU de Rouen ( Site 1013), Rouen, Seine-Maritime

Hopital Cochin ( Site 1002), Paris, Not set

Centro de Investigaciones Clinicas de Latinoamerica S.A. - CELAN ( Site 0602), Guatemala, Not set

Clinica Privada Dr. Rixci Ramirez ( Site 0601), Guatemala, Not set

INTERVASC ( Site 0605), Guatemala, Not set

Grupo Angeles SA ( Site 0604), Guatemala, Not set

Centro Regional de Sub Especialidades Médicas SA ( Site 0600), Quetzaltenango, Not set

Bacs-Kiskun Megyei Korhaz-Onkoradiologiai Kozpont ( Site 1106), Kecskemét, Bacs-Kiskun

Petz Aladar Megyei Oktato Korhaz ( Site 1110), Gyor, Gyor-Moson-Sopron

Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz Rendelointezet ( Site 1103), Szolnok, Jasz-Nagykun-Szolnok

Tudogyogyintezet Torokbalint ( Site 1105), Torokbalint, Pest

Veszprem Megyei Tudogyogyintezet ( Site 1108), Farkasgyepu, Veszprem

Zala Megyei Szent Rafael Korhaz ( Site 1111), Zalagerszeg, Zalaegerszeg

Semmelweis University-Pulmonológiai Klinika ( Site 1114), Budapest, Not set

Orszagos Koranyi Pulmonologiai Intezet ( Site 1104), Budapest, Not set

Fujita Health University Hospital ( Site 3007), Toyoake, Aichi

Ehime University Hospital ( Site 3005), Toon, Ehime

Kurume University Hospital ( Site 3006), Kurume, Fukuoka

National Hospital Organization Hokkaido Cancer Center ( Site 3014), Sapporo, Hokkaido

Kanazawa University Hospital ( Site 3004), Kanazawa, Ishikawa

Kanagawa Cardiovascular and Respiratory Center ( Site 3003), Yokohama, Kanagawa

Miyagi Cancer Center ( Site 3000), Natori, Miyagi

Sendai Kousei Hospital ( Site 3015), Sendai, Miyagi

Kurashiki Central Hospital ( Site 3013), Kurashiki, Okayama

Kansai Medical University Hospital ( Site 3016), Hirakata, Osaka

National Hospital Organization Kinki-chuo Chest Medical Center ( Site 3009), Sakai, Osaka

Osaka Medical and Pharmaceutical University Hospital ( Site 3017), Takatsuki, Osaka

Chiba University Hospital ( Site 3008), Chiba, Not set

National Hospital Organization Kyushu Medical Center ( Site 3001), Fukuoka, Not set

National Hospital Organization Kyushu Cancer Center ( Site 3002), Fukuoka, Not set

Okayama University Hospital ( Site 3012), Okayama, Not set

Osaka International Cancer Institute ( Site 3018), Osaka, Not set

Tokushima University Hospital ( Site 3019), Tokushima, Not set

Juntendo University Hospital ( Site 3011), Tokyo, Not set

Showa University Hospital ( Site 3010), Tokyo, Not set

Chungnam National University Hospital ( Site 2002), Daejeon, Chungnam

Chonnam National University Hwasun Hospital-Pulmonology ( Site 2000), Hwasun, Jeonranamdo

Korea University Guro Hospital ( Site 2003), Seoul, Not set

Hospital Nacional Carlos Alberto Seguin Escobedo ESSALUD ( Site 0704), Arequipa, Ariqipa

Clínica Peruano-Americana de Trujillo ( Site 0701), Trujillo, La Libertad

Oncosalud ( Site 0706), Lima, Muni Metro De Lima

Clinica Internacional Sede San Borja ( Site 0705), Lima, Not set

Instituto Nacional de Enfermedades Neoplasicas ( Site 0703), Lima, Not set

Hospital Nacional Cayetano Heredia ( Site 0700), Lima, Not set

Centrum Onkologii im prof Franciszka Lukaszczyka ( Site 1201), Bydgoszcz, Kujawsko-pomorskie

Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 1206), Siedlce, Mazowieckie

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warszawa, Mazowieckie

Centrum Pulmonologii i Torakochirurgii w Bystrej ( Site 1205), Bystra, Slaskie

Przychodnia Lekarska KOMED ( Site 1202), Konin, Wielkopolskie

Szpital Wojewodzki im. Mikolaja Kopernika ( Site 1200), Koszalin, Zachodniopomorskie

Cardiomed SRL Cluj-Napoca ( Site 1313), Cluj-Napoca, Cluj

Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 1303), Cluj-Napoca, Cluj

SC Radiotherapy Center Cluj SRL ( Site 1307), Comuna Floresti, Cluj

S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 1304), Craiova, Dolj

Centrul de Oncologie Oncolab-Medical Oncology ( Site 1312), Craiova, Dolj

Spitalul Municipal Ploiesti ( Site 1308), Ploiesti, Prahova

Policlinica Oncomed SRL ( Site 1302), Timisoara, Timis

S.C.Focus Lab Plus S.R.L ( Site 1301), Bucuresti, Not set

Spitalul Universitar de Urgenta Bucuresti ( Site 1305), Bucuresti, Not set

SPBU Clinic of Advanced medical technologies n.a. N. I. Pirogov ( Site 1406), Saint-Petersburg, Sankt-Peterburg

National Medical Research Center of Oncology N.A. N.N. Petrov ( Site 1407), Saint-Petersburg, Sankt-Peterburg

Saint-Petersburg Scientific-Practical Center of Specialized Kinds of Medical Care (o) ( Site 1424), Saint-Petersburg, Sankt-Peterburg

Republican Clinical Oncology Dispensary-Chemotherapy #1 ( Site 1425), Kazan, Tatarstan, Respublika

SPb SBHI City Clinical Oncological Dispensary ( Site 1409), Sankt-Peterburg, Not set

Wits Clinical Research ( Site 1510), Johannesburg, Gauteng

Steve Biko Academic Hospital ( Site 1506), Pretoria, Gauteng

Marry Potter Oncology Centre ( Site 1502), Pretoria, Gauteng

Sandton Oncology Medical Group PTY LTD ( Site 1505), Sandton, Gauteng

Chris Hani Baragwanath Academic Hospital-Wits Clinical Research Bara ( Site 1513), Soweto, Gauteng

The Oncology Centre ( Site 1507), Durban, Limpopo

Cape Town Oncology Trials Pty Ltd ( Site 1500), Kraaifontein, Western Cape

Hospital Insular de Gran Canaria-Oncology ( Site 1604), Las Palmas de Gran Canaria, Las Palmas

H.U. Vall de Hebron ( Site 1600), Barcelona, Not set

Hospital Juan Ramon Jimenez ( Site 1602), Huelva, Not set

Hospital Universitario Lucus Augusti ( Site 1603), Lugo, Not set

Hospital Universitario La Paz ( Site 1601), Madrid, Not set

Changhua Christian Hospital ( Site 2104), Changhua, Not set

National Taiwan University Hospital Hsin-Chu Branch ( Site 2103), Hsinchu, Not set

Kaohsiung Medical University Chung-Ho Memorial Hospital ( Site 2107), Kaohsiung, Not set

National Cheng Kung University Hospital ( Site 2105), Tainan, Not set

National Taiwan University Hospital ( Site 2101), Taipei, Not set

Taipei Veterans General Hospital ( Site 2106), Taipei, Not set

Chang Gung Medical Foundation-Linkou Branch ( Site 2102), Taoyuan, Not set

Gulhane Egitim ve Arastirma Hastanesi ( Site 1704), Ankara, Not set

Ankara Sehir Hastanesi ( Site 1702), Ankara, Not set

TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1701), Istanbul, Not set

Ege Universitesi Tip Fakultesi Hastanesi ( Site 1703), Izmir, Not set

Inonu Universitesi Turgut Ozal Tip Merkezi ( Site 1707), Malatya, Not set

Medical Center Mriya Med-Service ( Site 1805), Kryvyi Rih, Dnipropetrovska Oblast

Communal non profit enterprise Regional Clinical Oncology Center ( Site 1806), Kharkiv, Kharkivska Oblast

Ukrainian Center of Tomotherapy ( Site 1807), Kropyvnytskyi, Kirovohradska Oblast

Medical Center Asklepion LLC ( Site 1804), Khodosivka, Kyivska Oblast

Municipal non-profit enterprise'Odesa Regional Clinical Hosp-Thoracic surgery department. ( Site 181, Odesa, Odeska Oblast

Kremenchuk Regional Oncology Center ( Site 1811), Kremenchuk, Poltavska Oblast

Kyiv City Clinical Oncology Centre ( Site 1809), Kyiv, Not set

Medical Center Dobrobut Clinic ( Site 1808), Kyiv, Not set

Conditions: Non-Small Cell Lung Cancer

Learn More ›

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

NCT02009449

Completed

This is a first-in-human, open-label, dose escalation study to evaluate the safety and tolerability of pegilodecakin in participants with advanced solid tumors, dosed daily subcutaneously as a monotherapy or in combination with chemotherapy or immunotherapy.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/13/2024

Locations: UCLA Medical Hematology & Oncology, Los Angeles, California +9 locations

Conditions: Melanoma, Prostate Cancer, Ovarian Cancer, Renal Cell Carcinoma, Colorectal Carcinoma, Pancreatic Carcinoma, Non-small Cell Lung Carcinoma, Solid Tumors, Breast Cancer

Learn More ›

Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer

NCT03916419

Active Not Recruiting

Building upon the clinical experience of the investigators with the magnetic resonance (MR)-guided radiation therapy system and applying principals of hypofractionation toward the current treatment paradigm of concurrent chemoradiation and consolidation immunotherapy for locally advanced non-small cell lung cancer (NSCLC), this prospective, single-arm Phase II clinical trial with safety lead-in will test the feasibility and outcomes of this approach.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/12/2024

Locations: Washington University School of Medicine, Saint Louis, Missouri

Conditions: Stage IIB Non-Small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IIIC Non-Small Cell Lung Cancer

Learn More ›

Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT02312245

Completed

This phase II trial studies how well Avatar-directed chemotherapy works in treating patients with ovarian, primary peritoneal, or fallopian tube cancer that does not respond to platinum anti-cancer drugs. Drugs used in chemotherapy, such as paclitaxel, gemcitabine hydrochloride, pegylated liposomal doxorubicin hydrochloride, topotecan hydrochloride, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spre... Read More

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

11/12/2024

Locations: Mayo Clinic in Arizona, Phoenix, Arizona +2 locations

Conditions: Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma

Learn More ›

Browse by State

Paclitaxel treatment options in Alabama

Paclitaxel treatment options in Alaska

Paclitaxel treatment options in Arizona

Paclitaxel treatment options in Arkansas

Paclitaxel treatment options in California

Paclitaxel treatment options in Colorado

Paclitaxel treatment options in Connecticut

Paclitaxel treatment options in Delaware

Paclitaxel treatment options in District of Columbia

Paclitaxel treatment options in Florida

Paclitaxel treatment options in Georgia

Paclitaxel treatment options in Hawaii

Paclitaxel treatment options in Idaho

Paclitaxel treatment options in Illinois

Paclitaxel treatment options in Indiana

Paclitaxel treatment options in Iowa

Paclitaxel treatment options in Kansas

Paclitaxel treatment options in Kentucky

Paclitaxel treatment options in Louisiana

Paclitaxel treatment options in Maine

Paclitaxel treatment options in Montana

Paclitaxel treatment options in Nebraska

Paclitaxel treatment options in Nevada

Paclitaxel treatment options in New Hampshire

Paclitaxel treatment options in New Jersey

Paclitaxel treatment options in New Mexico

Paclitaxel treatment options in New York

Paclitaxel treatment options in North Carolina

Paclitaxel treatment options in North Dakota

Paclitaxel treatment options in Ohio

Paclitaxel treatment options in Oklahoma

Paclitaxel treatment options in Oregon

Paclitaxel treatment options in Maryland

Paclitaxel treatment options in Massachusetts

Paclitaxel treatment options in Michigan

Paclitaxel treatment options in Minnesota

Paclitaxel treatment options in Mississippi

Paclitaxel treatment options in Missouri

Paclitaxel treatment options in Pennsylvania

Paclitaxel treatment options in Rhode Island

Paclitaxel treatment options in South Carolina

Paclitaxel treatment options in South Dakota

Paclitaxel treatment options in Tennessee

Paclitaxel treatment options in Texas

Paclitaxel treatment options in Utah

Paclitaxel treatment options in Vermont

Paclitaxel treatment options in Virginia

Paclitaxel treatment options in Washington

Paclitaxel treatment options in West Virginia

Paclitaxel treatment options in Wisconsin

Paclitaxel treatment options in Wyoming